ACADIAN ASSET MANAGEMENT LLC – Regeneron Pharmaceuticals, Inc. Transaction History
ACADIAN ASSET MANAGEMENT LLC portfolio value:
$179.75M
portfolio value
ACADIAN ASSET MANAGEMENT LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -27.38% | -98.42K shares | -32.70M | $688.87 | 260.99K |
Q2 2022 | share | Decrease | -16.26% | -69.78K shares | -87.25M | $591.13 | 359.41K |
Q1 2022 | share | Decrease | -5.09% | -22.99K shares | 14.19M | $698.42 | 429.19K |
Q4 2021 | share | Decrease | -14.59% | -77.27K shares | -34.85M | $642.51 | 452.19K |
Q3 2021 | share | Increase | +19.88% | 87.81K shares | 73.69M | $605.18 | 529.46K |
Q2 2021 | share | Increase | +3.83% | 16.27K shares | 45.42M | $558.54 | 441.65K |
Q1 2021 | share | Increase | +351.47% | 331.15K shares | 155.74M | $473.14 | 425.37K |
Q4 2020 | share | Decrease | -1.34% | -1.27K shares | -7.94M | $483.11 | 94.22K |
Q3 2020 | share | Increase | +19.05% | 15.28K shares | 3.42M | $559.78 | 95.49K |
Q2 2020 | share | Increase | +2150.18% | 76.65K shares | 48.29M | $623.65 | 80.21K |
Q1 2020 | share | Increase | +85.00% | 1.63K shares | 1.01M | $488.29 | 3.56K |
Q4 2019 | share | Increase | +108.78% | 1.00K shares | 468K | $375.48 | 1.92K |
Q3 2019 | share | Decrease | -53.57% | -1.06K shares | -366K | $277.4 | 923 |
Q2 2019 | share | Decrease | -58.79% | -2.83K shares | -1.35M | $313 | 1.98K |
Q1 2019 | share | Decrease | -79.57% | -18.79K shares | -6.84M | $410.62 | 4.82K |
Q4 2018 | share | Increase | +11.73% | 2.47K shares | 281K | $373.5 | 23.61K |
Q3 2018 | share | Increase | +1322.27% | 19.64K shares | 8.02M | $404.04 | 21.13K |
Q2 2018 | share | Increase | 0.00% | 1.48K shares | 513K | $344.99 | 1.48K |
Q1 2018 | share | Decrease | -100.00% | -202 shares | -76K | $344.36 | 0 |
Q4 2017 | share | Decrease | -56.47% | -262 shares | -132K | $375.96 | 202 |
Q3 2017 | share | Decrease | -68.98% | -1.03K shares | -527K | $447.12 | 464 |
Q2 2017 | share | Increase | +2132.84% | 1.42K shares | 709K | $491.14 | 1.49K |
Q1 2017 | share | Decrease | -69.27% | -151 shares | -55K | $387.51 | 67 |
Q4 2016 | share | Decrease | -70.30% | -516 shares | -214K | $367.09 | 218 |
Q3 2016 | share | Decrease | -61.02% | -1.14K shares | -362K | $402.02 | 734 |
Q2 2016 | share | Increase | +161.89% | 1.16K shares | 398K | $349.23 | 1.88K |
Q1 2016 | share | 0.00% | 0 shares | -131K | $360.44 | 719 |